未登录 分享 收藏
分享 收藏
分享 收藏
分享 收藏
Perioperative toripalimab plus neoadjuvant chemotherapy might improve outcomes in resectable esophageal cancer: an interim analysis of a phase III randomized clinical trial Zheng, Yan; Liang, Guanghui; Yuan, Dongfeng; Liu, Xianben; Ba, Yufeng; Qin, Zimin; Shen, Sining; Li, Zhenxuan; Sun, Haibo; Liu, Baoxing; Gao, Quanli; Li, Peng; Wang, Zongfei; Liu, Shilei; Zhu, Jianping; Wang, Haoran; Ma, Haibo; Liu, Zhenzhen; Zhao, Fei; Zhang, Jun; Zhang, He; Wu, Daoyuan; Qu, Jinrong; Ma, Jie; Zhang, Peng; Ma, Wenjie; Yan, Ming; Yu, Yongkui; Li, Qing; Zhang, Jiangong; Xing, Wenqun 分享 收藏
分享 收藏
Pembrolizumab plus lenvatinib (PL) in recurrent clear cell gynecological cancer (CCGC): Phase II LARA trial (GCGS-OV4/APGOT-OV3) 帕博利珠单抗联合仑伐替尼(PL)在复发性透明细胞妇科肿瘤(CCGC)中的疗效:II期LARA试验(GCGS-OV4/APGOT-OV3) Ngoi, N.; Lee, J-Y.; Lim, D.; Thian, Y. L.; Lim, Y. W.; Chan, J. J.; Chay, W. Y.; Zhang, Z.; Gopinathan, A.; Lim, S. E.; Low, J.; Ng, J.; Tong, P.; Lee, Y. J.; Park, J.; Kim, J-W.; Zhu, J.; Tai, B. C.; Kim, B-G.; Tan, D. S. 分享 收藏
分享 收藏